secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2024-12-11T23:59:59+00:00
Accession:  0000950170-24-135204
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum Therapeutics upsizes ATM offering by up to $25M, previously raised $16M
------------------------------------------------------------------------------

- Filed prospectus supplement on Dec 10, 2024 for additional gross proceeds up to $25M.
- Prior sales under same ATM agreement totaled approx $16M gross proceeds.
- Sales agent is H.C. Wainwright & Co., LLC under agreement dated Oct 7, 2022.
- Shares offered via S-3 registration statement; legal opinion from A&L Goodbody LLP attached.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000095017024135204/0000950170-24-135204-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000095017024135204/itrm-20241210.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-135204

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer